Arcturus Therapeutics Holdings Inc (NQ:ARCT)

We have researched tech stocks for you and have found these three are likely multibaggers in the making. Considering picking them up today.

3 Tech Stocks That Could Be Multibaggers in the Making: February Edition ↗

February 20, 2024

Arcturus Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 7, 2024

February 20, 2024

Is ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT) suited for growth investing?

Is NASDAQ:ARCT suited for growth investing? ↗

February 06, 2024

Via Chartmill

Arcturus Therapeutics: Q3 Earnings Insights ↗

November 14, 2023

Via Benzinga

New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster

February 05, 2024

From Arcturus Therapeutics

Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 23, 2024

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 20 points on Tuesday.

Via Benzinga

Topics Stocks

Why the growth investor may take a look at ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT). ↗

January 16, 2024

ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT) showing high EPS and FCF growth while beating expectations ↗

December 26, 2023

Exploring growth characteristics of ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT).

Via Chartmill

CSL and Arcturus Therapeutics’ ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster

December 21, 2023

From Arcturus Therapeutics

While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar ↗

December 17, 2023

These biotech stocks with promising pipelines are showing some major promise and growth potential for the new year.

3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024 ↗

December 13, 2023

Arcturus Therapeutics' Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside ↗

December 13, 2023

Canaccord Genuity has initiated coverage on Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT), a player in the genetic medicine space.

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

December 04, 2023

Via Benzinga

Arcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 04, 2023

ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT) may be suited for growth investing, we'll explore why in this article.

Why the growth investor may take a look at NASDAQ:ARCT. ↗

December 04, 2023

Via Chartmill

Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics’ ARCT-154, the First Self-Amplifying mRNA Vaccine Approved for COVID in Adults

November 28, 2023

Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-032, for the Treatment of Cystic Fibrosis

November 27, 2023

Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday ↗

November 15, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Shares of Target Corporation (NYSE: TGT) jumped during Wednesday’s session after the company reported...

Via Benzinga

Topics Earnings Stocks

Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 15, 2023

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.

Via Benzinga

Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket ↗

November 15, 2023

Shares of CorMedix Inc. (NASDAQ: CRMD) surged in pre-market trading as the company posted a narrower-than-expected third-quarter loss. Cormedix posted a loss of 17 cents per share for the third...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 15, 2023

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news worth reading about on Wednesday!

Arcturus Therapeutics Announces Third Quarter 2023 Financial Update and Pipeline Progress

November 14, 2023

Given the undervalued biotech industry, these three undervalued biotech stocks to buy are ripe purchase targets for high-potential profits.

The 3 Most Undervalued Biotech Stocks to Buy: November 2023 ↗

November 14, 2023

Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 14, 2023

October 25, 2023

Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences

October 23, 2023

Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded Additional Financial Grants from Japanese Government

October 04, 2023

Arcturus Therapeutics and Cystic Fibrosis Foundation Extend Agreement to Advance ARCT-032, an Investigational Messenger RNA (mRNA) Therapeutic to Treat Cystic Fibrosis

A Look Into Healthcare Sector Value Stocks ↗

October 02, 2023

Via Benzinga

September 26, 2023

Study Shows Novel sa-mRNA Vaccines Offer Robust, Broad, Enduring Protection Against COVID-19 Variants

September 19, 2023